Welcome to Prospect - a support group for prostate cancer patients, their wives, partners and carers.
Prospect is run by prostate cancer survivors for the benefit of the communities in Bristol and surrounding districts

  • Prostate guidance ‘wrong’

    Public health messaging around PCa places a misleading focus on urinary symptoms and may be hampering efforts of early detection, scientists have warned. Researchers said there was “no evidence of a causal link between PCa and either prostate size or troublesome urinary symptoms”. But public health guidance regularly promotes this link. More here Worried about  PCa? Check here in 30 seconds

  • Prospect gift for brave cyclist

    Chairman Tim Bond presents a Prospect cheque to round-Britain cyclist Kevin Baldwin at Clifton Suspension Bridge on May 30. Kevin is making the trip to raise funds for cancer research. Latest news in August was that Kevin had passed John O’Groats in the north of Scotland and he’s raised at least £14,000 so far! You can follow his trip at @compass4cancer

    The next coffee morning is on Sept 1, 10am-noon, at Penny Brohn centre, Chapel Pill Lane, Pill, BS20 0HH. Need a lift to the event? We arrange pick-up points close to a bus stop near you. Email details to prospect.bristol@gmail.com a few days in advance. Lifts will usually be timed to arrive at Penny Brohn at 10am unless the driver agrees to another time.

    There will be a walk at Ashton Court on Oct 7 and a general meeting at BAWA on Nov 7.

    Want our newsletter and details of our group? Email prospect.bristol@gmail.com with your postal address and we will send you an information pack.

    Biopsies out with new scan

    A new type of MRI scan could help doctors rule out PCa more regularly, potentially saving thousands of men from undergoing unnecessary biopsies. More here

    Step out for victims

    March the Month in Sept is a virtual step challenge for anyone who wants to keep active and help beat PCa. Whether you’re walking or wheeling, take on 11,000 steps a day throughout the month. You’ll be doing it for more than 11,000 dads, partners, brothers, grandads and mates who die from PCa every year. Sign up here

    Iron ‘kills recurring cancer’

    Scientists have early evidence that one way to kill recurring cancer cells may be with a lot of iron. More here

    ‘Cure found’

    Scientists discover a new molecule that kills even the deadliest cancer, but no mention of PCa. See more here

    Chemists to tackle cancer

    People with a worrying cough, problems swallowing or blood in their urine will soon be able to be referred for scans and checks by a pharmacist, rather than by their GP. A new pilot scheme, in England, aims to diagnose more cancers early, when there is a better chance of a cure. The NHS also plans to offer Jewish people genetic screening – as up to one in 40 has Brca mutations, linked to a higher risk of breast, ovarian and prostate cancers, compared with one in 400 in the general population.

    Bad news about milk

    Drinking milk has links to PCa, it’s alleged. More here. But better news about a cancer killer here

    AGM re-elects officers

    The AGM heard a talk on the role of exercise in cancer recovery and then re-elected the officers and committee with the addition of Jeff Allen. A YouTube  recording of the talk is available here .

    Urine bugs ‘a sign of aggressive PCa’

    Scientists say they have identified urine bacteria which are linked to aggressive PCa. The discovery might provide new ways to spot and even prevent these dangerous tumours, experts hope. See more And scientists have hypothesised that if they found a way to get zinc into malignant cells that might be helpful. More here

    PCa growth discovery

    A research team has discovered specific changes in a protein that drive the growth and spread of PCa. See more here

    Fast blood test for cancer tested

    A new PinPoint blood test being tested could rule out cancer for 500,000 people a year, with the results back from the NHS within just two or three days (Mar ’22). More here

    New test cuts false positives

    Men could be screened for PCa using a new blood test which significantly reduces the number of distressing false positives, according to new research. A UCL scientist found that by using tests that look for two different warning signs together, instead of just one, it was possible to better identify those with the disease (Mar ’22). See more here

    Talk on YouTube

    The talk we had by Sarah Gray of Tackle has been put on YouTube here

    New drug ‘prolongs life’

    A breakthrough triple therapy for advanced PCa can give patients years more healthy life and reduces the overall risk of death by a third. The regime involves two standard therapies alongside a powerful new hormone medication, darolutamide (Mar ’22). More here

    Gap for Black men closed and help needed

    A new programme to close the gap for Black men with PCa was announced by Prostate Cancer Research in August. See more here And Participants aged 18+ are needed to examine how Black men use recorded music/song choices to process the impact of their PCa. The study also seeks to enable the future development of culturally appropriate peer support groups for psychosocial help using music. Tackle Director Alphonso Archer, a music therapy master’s student at the UWE, will conduct the research online. This should take about 60-90 minutes to complete in the form of a semi-structured interview. To find out more and to participate go here, And In partnership with Movember, Prostate Cancer UK is funding a study to help find out why Black men are at higher risk of PCa than other ethnic groups. More here  And Prostate Cancer Research announced an initial £875k investment in finding answers to Black men’s higher risks of diagnosis and death. Black men are twice as likely to get PCa and 2.5 times more likely to die from it than White men. Five new projects launched to specifically tackle this inequity. More here

    Help with treatment decisions

    Prostate Cancer Research is launching a new website to empower people living with PCa to make better treatment decisions. You can sign up to share your experiences on The Infopool when it launches later this year (Feb ’22). Sign up here And the Predict Prostate web tool helps you make decisions about PCa treatment.

    Search on for 14,000 untreated men

    A hunt is on for 14,000 men who it’s estimated haven’t started PCa treatment due to the pandemic (Feb ’22). Men are asked to answer three quick questions at this risk checker: The ‘Find the 14,000 men’ campaign by Prostate Cancer UK has been nominated for the NHS Communinications Initiative of the Year Award at the 2022 Health Service Journal Awards (Aug ’22).

    New test spots aggressive cancers

    A new test can spot which prostate cancers are most deadly (Feb ’22). More here

    Exercises ‘a boon’

    Any cancer diagnosis is a major challenge. While waiting for treatment we can improve our readiness by getting fitter. Any improvement speeds recovery. Recovery after treatment is both psychological and physical. Exercise helps both. When it takes place in a friendly group of people each facing their own cancer journeys the benefits multiply. For me, the Energise programme has been one of the best things I have done to help my recovery. It is a personalised exercise programme designed by specialists for you. It starts from where you are. You do not need to be a fitness fanatic or have any previous experience. It really is designed for helping you to start from your level of fitness – or unfitness – and support you through whatever challenges you face. I attend the classes at Everyone Active Stadium, Clevedon, where more people will be very welcome. There are also classes in Bristol. Tim Bond, chairman.  Apply here. More info available from Alistair MacFarlane at alistairmacfarlane@everyoneactive.com

    Statins and PCa

    Studies have found that men taking statins are less likely to have PCa in routine screenings. Another found that statin users were less likely to die from PCa (Feb ’22). See more here

    Pioneering new treatment

    Nanoknife surgery was used to treat NHS PCa patients for the first time in January in London. MRI positions electrodes precisely around the tumour, and a series of short electric pulses kill off cancer cells. Healthy cells are not damaged, reducing the risk of side effects and many patients recover more quickly. Nanoknife can also be carried out as a day surgery, reducing pressure on the NHS. More here

    Don’t delay cancer checks!

    The public are being urged not to put off seeking help for worrying cancer symptoms because of NHS pressures. See more here

    Join registry for info

    PCa Research are seeking men to join a first-of-its-kind registry. It would revolutionise PCa  diagnosis, treatment and care by putting real people at the centre of it all. But joining would not only benefit others. You would also be able to access more relevant information about your treatment and care, be kept informed about the most relevant clinical trials you are eligible for, and provide critical evidence to speed up and shape vital research. Sign up here

    Writing as therapy

    Discover the therapeutic benefits of creative writing in a safe, supported group. No previous writing experience needed. Referrals on to the Fresh Arts Creative Writing for Wellbeing programme are being accepted by North Bristol NHS Trust, with new programme as follows: The meetings are all 10-noon on Thurs: June 16-July 21; Sept 14–Oct 20; Jan 5–Feb 9 2023. To find out more and book a place email fresh.arts@nbt.nhs.uk; visit NGS Macmillan Wellbeing Centre Reception; or call Donna Baber, Fresh Arts Manager, on 07554 334 828.

    Bladder problems?

    A project has been launched to initiate positive change for those affected by bladder and bowel conditions (Nov ’21). See more and register here

    Nutrition and prostate cancer

    A video of the Prostate Cancer Research webinar session on this subject is available here A copy of the presentation is available here  For more information or how to contact the presenters visit here

    Good news for advanced patients

    Apalutamide has been approved, Prostate Cancer UK reports. It means hormone treatment willl now be offered to those with advanced PCa who cannnot or should not receive chemotherapy as well as those who have become resistant to tranditional hormone therapies (Sept ’21).

    Enzalutamide (Xtandi) approved

    Important news from NICE for the 4,100 men each year who are unsuitable for the standard treatment of docetaxel chemotherapy and who have, until now, had limited treatment options (June ’21).  More here:

    New vaccine ‘could prevent PCa’

    See here

    Bad news re Olaparib

    Olaparib has given new hope to men with incurable PCa, says the Daily Mail in this article. But in January NICE said it intends to reject Olaparib for men in England, Wales and Northern Ireland, just months after it was approved in Scotland. See more here

    Big change in PCa diagnosis

    The biggest diagnostic development in PCa diagnosis for 50 years – that came about when NICE advised that all men at risk of PCa should have an MRI before a biopsy. The change has had a worldwide effect. See more here

  1. RunningWe are a friendly and supportive network that meets at BAWA, Filton. Meeting details and directions are in the column on the left. You can contact us via the Tackle helpline, which will put you in touch with us: 0800 035 5302.

Our chairman and secretary

Tim Bond, below, was elected chairman of Prospect at the 2021 AGM. He replaces Malcolm Gamlin, who retired after 13 years in the role. Malcolm was thanked for his hard work.

Tim Bond gave a talk to Weston Masons in April that was well received by a friendly bunch. Several had experience of prostate cancer so it felt very like Prospect’s Thursday meetings. The Athelstan Lodge Masons in Weston-super-Mare generously donated £250 to Prospect.

Mick Broggio resigned as secretary but volunteer Martin Webb was co-opted by the committee  and elected at the 2021 AGM. Other committee members were re-elected at the AGM too with the addition of Jeff Allen, below.

Our group aims to:

We have found that knowledge is of great benefit to the patient. It enables him to play an active part in the decision-making process, for example in selecting the best treatment.

This site has been compiled by PCa survivors. We don’t claim to have specialist knowledge other than that gained by PCa patients during their treatment.

We offer a friendly welcome – join us

Are you just diagnosed, or do you suspect that you may have prostate cancer? Then for friendly peer support and an introduction to Prospect email prospect.bristol@gmail.com or call the Tackle helpline, which will put you in touch with us: 0800 035 5302. You can join us for a small subscription by filling in the PDF membership form on the Contact/Join us page.

Memorial to PCa victims – add a name

You can add a loved-one’s name to a Prostate Cancer UK memorial that is touring the UK. See how here There is also a Facebook page about the memorial’s tour here The memorial is now in Newcastle at Eldon Square Shopping Centre. It will be there until Sept 13. A new set of landmark locations will be announced over the next few months. Keep up to date with the memorial and where it’s travelling to next on that Facebook page.

Protected from despair…

George Monbiot writes in the Guardian that the principles that define a good life protect him from despair, despite a diagnosis of prostate cancer and the ‘grisly’ operation he faces (Mar ’18). See here

We give illustrated talks

We give prostate cancer awareness talks to interested groups, including those with learning disabilities. To arrange a talk, contact prospect.bristol@gmail.com or 0800 035 5302.

Having the conversation…

“Manversation” is a campaign to encourage men to speak about prostate cancer, particularly the advanced prostate form. Tackle have collaborated with Orchid, the male cancer charity, and put their name to a video and supporting material on the Manversation website, but this site is undergoing essential maintenance in preparation for a new campaign, coming soon.

Myths debunked and spotting fake cancer news

Ten cancer myths debunked. See here. And also here are six tips to spot cancer fake news

New information for at-risk black men

One in four black men will get prostate cancer – double the overall risk faced by all UK men. Are you are risk? See here

Energise wins award

The exercise-based cancer rehab programme Energise won the Together We Achieve award for 2016. The award, announced at the inaugural Health & Care Awards in March ’17, recognises teams working together to deliver improved patient care and public health. See a video about their work here.

For more information on Energise see our Helpful links page.

New research strategy launched

Prostate Cancer UK has launched an ambitious 10-year strategy setting out how it will invest in the most innovative research to create a step change in our knowledge of prostate cancer. See here. The charity also says PCa survival has tripled in the UK over the past 40 years. More than eight in 10 patients are alive ten years after diagnosis – up from one in four in the 1970s.

And we have more research news here.

Swedish test dropped

Swedish researchers found a test which showed promise and seemed much better than PSA alone at detecting potentially dangerous prostate cancers. But now Prostate Cancer UK says the Swedish test, while it has had some uptake in some Scandinavian countries, it has not seen the same uptake elsewhere. Prostate Cancer UK said it had initially intended to support some research towards its use in the UK, but this did not materialise and the field has advanced somewhat since then. It is considering a number of other options which could prove to be more effective than PSA as a diagnostic test, and as specified in its revised research strategy, it is intending large-scale investment to support the development of a screening programme for PCa. The charity hopes to be able to provide an update about this in due course.

Tiger or pussycat? That’s the problem

It’s a big problem to tell the difference between slow-growing cancers and aggressive ones. See here

Cancer ‘as unique as fingerprints’

Each person’s cancer is as unique as their fingerprints, said Professor Gillies McKenna, Director of the CRUK/MCR Oxford Institute for Radiation Oncology. This created an opportunity for more precise treatment.

Back to top

  • Know your risk

    Prostate Cancer UK has a new infographic and booklets.

    Exchange information

    www.myprostate.eu is now also available in English and prostate cancer patients can exchange information and help each other with treatment decisions.

  • Help with treatment choices

    Get enhanced guidance on treatment options, thanks to a checklist developed by researchers (Jun ’17). See. More help here. And why it’s difficult to choose among treatment options (Jul ’17). See. Men with early stage prostate cancer wishing to preserve sexual function while on treatment do not always make the right choices. See

  • Buddies home support update

    This Macmillan service offered support for adult cancer patients in our areas and they have been working on re-starting  face-to-face visits again. The Bristol Buddies service has moved to its national telephone service. Ring 07543 248714 or see this site for support.